Medical Marijuana Use in HIV+ Patients: Probability Survey (MMS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01536912 |
|
Recruitment Status
:
Completed
First Posted
: February 22, 2012
Last Update Posted
: July 30, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
More scientific information is needed about medical marijuana use among HIV positive patients. There is conflicting information about the use of marijuana, use of medical marijuana, and the associations between them and health status/health risk behaviors/health care utilization. In addition, it is not clear whether patients who participate in prospective clinical studies differ from participants who do not participate; if there are differences between those two groups, then this would limit generalizability of knowledge about these issues.
The goal of this project is to describe the use of marijuana among HIV positive patients and its association with health status/health risk behaviors/health care utilization.
| Condition or disease |
|---|
| HIV Positive |
Participants will answer questions about marijuana, medical marijuana, and other drug use. We will also ask about health and steps participants take to keep healthy. The study will take up to one hour to complete.
Participants will also be asked to sign a release of information form. This form would allow us to look at medical records at the HIV clinic.
| Study Type : | Observational |
| Actual Enrollment : | 218 participants |
| Observational Model: | Case-Only |
| Official Title: | Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients: Probability Survey |
| Study Start Date : | February 2012 |
| Actual Primary Completion Date : | December 2014 |
| Actual Study Completion Date : | December 2014 |
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients in the HIV clinic
- HIV positive
Exclusion Criteria:
- Lack of english
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01536912
| United States, Michigan | |
| Wayne State University (HIV clinic, Tolan Park Medical Building) | |
| Detroit, Michigan, United States, 48201 | |
| Principal Investigator: | Mark Greenwald, PhD | Wayne State University |
| Responsible Party: | Mark Greenwald, PhD, Professor, Wayne State University |
| ClinicalTrials.gov Identifier: | NCT01536912 History of Changes |
| Other Study ID Numbers: |
MMS-1 R01DA032678 ( U.S. NIH Grant/Contract ) |
| First Posted: | February 22, 2012 Key Record Dates |
| Last Update Posted: | July 30, 2015 |
| Last Verified: | July 2015 |
Keywords provided by Mark Greenwald, PhD, Wayne State University:
|
HIV positive |
Additional relevant MeSH terms:
|
HIV Seropositivity HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |